Research & Discovery
The latest research news in genetics and genomics.
COVID-19 Severity Could Be Linked to Patient Autoantibody Levels
In a study published this week, a team led by New York University researchers found patients with high autoantibodies were more likely to have severe COVID-19.
SomaLogic Revenues Almost Triple in First Half of 2021
For the six months ended June 30, the Boulder, Colorado-based company posted revenues of $38.6 million, up from $13.4 million in the year-ago period.
SomaLogic to List on Nasdaq Following SPAC Merger, Raises $630M
Through the transaction, which values SomaLogic at roughly $1.2 billion, the company received gross cash proceeds of approximately $630 million.
Sera Prognostics' Revenues, Loss Tick up in Q2
The preterm-birth diagnostics company, which went public in July, posted revenues of $20,000, up from $6,000 in the year-ago period.
SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent
The company said that it expects to exceed its previous full-year 2021 guidance of $66.7 million in revenues by 10 percent or more.